Skip to main content
. 2023 Apr 20;12:e83118. doi: 10.7554/eLife.83118

Author response table 1.

Exposure Outcome Method P OR LCI UCI
Telemore Length (Colocalised SNPs) Lung Cancer Inverse variance weighted 3.93E-06 2.21 1.58 3.10
Telemore Length (Colocalised SNPs) Lung Adenocarcinoma Inverse variance weighted 2.91E-07 3.48 2.16 5.60
Telemore Length (Colocalised SNPs) Lung Squamous Cell Carcinoma Inverse variance weighted 0.427 1.25 0.72 2.19
Telemore Length (Colocalised SNPs) Lung Small Cell Carcinoma Inverse variance weighted 0.691 0.822 0.31 2.19
Telemore Length (Colocalised SNPs) Lung Ever Smokers Inverse variance weighted 0.008 1.79 1.16 2.74
Telemore Length (Colocalised SNPs) Lung Never Smokers Inverse variance weighted 0.122 3.01 0.74 12.20
Telemore Length (Non-Colocalised SNPs) Lung Cancer Inverse variance weighted 2.36E-08 1.51 1.31 1.74
Telemore Length (Non-Colocalised SNPs) Lung Adenocarcinoma Inverse variance weighted 5.85E-15 2.38 1.91 2.96
Telemore Length (Non-Colocalised SNPs) Lung Squamous Cell Carcinoma Inverse variance weighted 0.293 0.89 0.72 1.10
Telemore Length (Non-Colocalised SNPs) Lung Small Cell Carcinoma Inverse variance weighted 0.852 1.03 0.76 1.39
Telemore Length (Non-Colocalised SNPs) Lung Ever Smokers Inverse variance weighted 8.35E-06 1.44 1.23 1.69
Telemore Length (Non-Colocalised SNPs) Lung Never Smokers Inverse variance weighted 1.03E-03 1.85 1.28 2.66